Document:

Exhibit
10.02

 

EMPLOYMENT
AGREEMENT

 

THIS
EMPLOYMENT AGREEMENT (“Agreement”) is dated as of March 8, 2021 (the “Effective Date”),
by and between MOUNTAIN HIGH ACQUISITIONS CORP., a Colorado corporation (the “Company”), and DAVID AQUINO,
an individual (the “Executive”).

 

BACKGROUND
INFORMATION

 

WHEREAS,
the Company has entered into that certain Exchange Agreement (the “Exchange Agreement”) dated as of March 8,
2021 with Kafkaford Holdings, Inc dba Certain Supply (“CS”) and the shareholders of CS including Executive
pursuant to which the Company agreed to acquire all of the capital stock of CS in exchange for shares of the Company’s Common
Stock (the “Transaction”);

 

WHEREAS,
a condition to the obligation of the parties to close the Transaction is that Executive and the Company shall have entered into
an employment agreement; and

 

NOW,
THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Company and Executive agree as follows:

 

OPERATIVE
PROVISIONS

 

1.
Employment and Duties.

 

1.1.
Subject to the terms and conditions of this Agreement, the Company shall employ the Executive, commencing on the Effective Date,
to serve as Chief Operating Officer of the Company and President of CS, and the Executive accepts such employment and agrees to
perform such reasonable responsibilities and duties commensurate with the aforesaid positions, and as directed by the Chief Executive
Officer of the Company. The Executive agrees to devote his full-time efforts to his employment duties at the Company and CS. Executive
also agrees to serve on the Company’s Board of Directors (the “Board”) and any committee(s) thereof as
requested by the Board.

 

1.2.
During the Term, the Executive’s principal place of employment shall be at such location or locations as determined from
time to time by the Board, but unless other agreed by Executive within Orange County California, consistent with the needs of
the Company and as required in connection with the performance of the Executive’s duties and responsibilities hereunder.
The Executive acknowledges that the Executive’s duties and responsibilities shall require the Executive to travel on business
to fully perform the Executive’s duties and responsibilities hereunder.

 

1.3.
Executive shall at all times be subject to, observe and carry out such rules, regulations and policies as the Company may from
time to time establish including the Company’s Code of Ethics and Insider Trading Policy. Executive further understands
that as an officer and director of a company whose shares are registered under the Exchange Act of 1934 (the “Exchange Act”)
he is subject to the reporting obligations under Section 16 of the Exchange Act.

 

1.4.
During the Term, the Executive shall use the Executive’s best efforts to faithfully and diligently serve the Company and
shall not act in any capacity that is in conflict with the Executive’s duties and responsibilities hereunder. For the avoidance
of doubt, during the Term the Executive shall not be permitted to become engaged in or render services (including outside board
positions) for any person or entity other than the Company and its subsidiaries and affiliates without the prior written approval
of the Board. Notwithstanding the foregoing, the Executive may (i) serve on the board or similar body of charitable and philanthropic
organizations; and (ii) manage his personal investments (collectively the “Permitted Activities”); provided
that the Executive’s involvement with the Permitted Activities does not interfere with the performance of the Executive’s
duties and responsibilities hereunder, is not in conflict with the business interests of the Company and does not otherwise compete
with the business of the Company. If the Board requests that the Executive serve as a director of one or more companies other
than CS owned directly or indirectly by the Company, Executive shall so serve without additional compensation hereunder.

 

2.
Term. The term of employment under this Agreement shall commence as of the Effective Date and shall continue until the
second anniversary of the Effective Date (the “Expiration Date”), provided that on the Expiration Date
and each subsequent anniversary of the Expiration Date, the term of the Executive’s employment under this Agreement shall
be extended automatically for successive one-year terms unless either party provides written notice to the other party at least
60 days prior to the Expiration Date (or such anniversary, as applicable) that the Executive’s employment hereunder shall
not be so extended; provided, however, that the Executive’s employment under this Agreement may be terminated
at any time pursuant to the provisions of Section 4. The period of time from the Effective Date through the Expiration Date and
each successive one-year renewal term is herein referred to as the “Term.”

 

3.
Compensation.

 

3.1.
Annual Salary. During the Term, the Company shall pay the Executive a base salary as follows: for the first 12 months commencing
on the Effective Date at the rate of $180,000 per annum (the “Base Salary”), which Base Salary in any subsequent
12 month period shall be increased to $360,000 per annum at the first instance that the average of the closing prices for the
Company’s Common Stock over a consecutive seven trading day period exceeds $0.25 (subject to adjustment for any stock splits,
recapitalization and similar events) all payable at the times and in the manner dictated by the Company’s standard payroll
policies.

 

3.2.
Other Compensation and Benefits. During the Term, as additional compensation, the Executive shall be entitled to receive
the following:

 

3.2.1.
Signing Bonus. The Company shall pay the Executive a one-time signing bonus in the amount of $100,000, no later than 45
days after the Effective Date.

 

3.2.2.
 Annual Bonus. The Executive shall receive an annual bonus (“Annual Bonus), on the first
anniversary of the Effective Date of $180,000 to be paid in restricted shares of the Company’s Common Stock based on the
average of the closing prices for the seven trading days immediately preceding the first anniversary of the Effective Date. On
the second and subsequent anniversaries, the Executive shall receive an Annual Bonus in the amount of $360,000 to be paid in restricted
shares of the Company’s Common Stock based on the average of the closing prices for the seven trading days immediately preceding
the applicable anniversary date if the average of the closing prices for the consecutive seven trading days immediately prior
to the end of such 12-month period exceeds $0.25 (subject to adjustment for any stock splits, recapitalizations and similar events).

 

3.2.3.
Performance Bonus. If on the first anniversary of the Effective Date, the average of the closing prices for the consecutive
seven trading days immediately preceding such date is at least $0.25 (subject to adjustment for any stock splits, recapitalizations
and similar events), the Executive shall be granted an award of 4,000,000 restricted shares of the Company’s Common Stock
as such numbers may be adjusted based on stock splits, recapitalizations and similar events (the “Equity Award”).
On the second and subsequent anniversaries, the Executive shall also receive the Equity Award if the average of the closing prices
for the consecutive seven trading days immediately preceding the applicable anniversary date exceeds $0.35 (subject to adjustment
for any stock splits, recapitalizations and similar events) as such numbers may be adjusted for stock splits, recapitalizations
and similar events.

 

3.2.4.
Benefits. The Executive shall be eligible to participate in and receive all benefits under the Company’s employee
benefit plans and programs, including (i) at the Company’s expense, medical, dental, vision and life insurance coverage
for the Executive and Executive’s dependents and (ii) any retirement savings plans or programs, and such other benefits
as the Company may, from time to time and in its sole discretion, make generally available to the employees of the Company, subject
to such eligibility provisions and the other terms and conditions of such plans, programs and perquisites, as may be in effect
from time to time. The Company may alter, modify, terminate, add to or delete any of its employee benefit plans at any time as
the Company, in its sole judgment, determines to be appropriate, without recourse by the Executive.

 

3.2.5.
Vacation. The Executive will be entitled to paid vacation time in accordance with the Company’s personnel policies
and procedures, as the same may change from time to time, or as otherwise determined by the Board, but in no event less than four
weeks per year.

 

3.3.
Expense Reimbursement. The Company shall pay or reimburse the Executive for all reasonable, customary and necessary business
expenses incurred or paid by the Executive in the performance of his duties and responsibilities hereunder, subject to any maximum
annual limit and other restrictions on such expenses set by the Company and to such reasonable substantiation and documentation
and other requirements as may be specified by the Company from time to time.

 

4.
Termination.

 

4.1.
By the Company For Cause. Notwithstanding any other provisions to the contrary contained herein, the Company may terminate
the Executive’s employment under this Agreement immediately for Cause upon written notice to the Executive, in which event
the Company shall be obligated to pay the Executive only (i) that portion of the Base Salary earned but not paid through the date
of termination and (ii) any business expenses incurred by the Executive but unreimbursed on the date of termination, provided
that such expenses and required substantiation and documentation thereof are submitted within thirty (30) days of termination
and that such expenses are reimbursable under Company policy (the “Accrued Amounts”). For purposes of this
Agreement, “Cause” shall mean: (i) the Executive breaches any material obligation, duty or agreement under
this Agreement or any other written agreement that the Executive has entered into with the Company or its affiliates; (ii) the
Executive commits any act of material dishonesty or undisclosed conflict of interest that is injurious to the Company, fraud,
breach of fiduciary duty involving the Company and its subsidiaries; (iii) the Executive is indicted for, convicted of or pleads
guilty or nolo contendere with respect to, (A) theft, fraud, or a felony under federal or applicable state law or (B) any
crime involving the business affairs of the Company; (iv) the Executive commits any act of misconduct that, in the reasonable
opinion of the Board gives rise to a material risk of liability under federal or applicable state law for discrimination or sexual
or other forms of harassment or other similar liabilities to subordinate employees; or (v) the Executive commits substantive violations
of specific directions of the Board, which directions are consistent with this Agreement and the Executive’s positions.
No termination by the Company for Cause pursuant to prongs (i), (iv) or (v) in the preceding sentence will be effective unless
(A) the Company gives written notice to the Executive specifying in reasonable detail the circumstances claimed to provide the
basis for such termination and provide an opportunity to cure such breach or violation and (B) such breach or violation is not
cured or corrected within thirty (30) days of notice thereof from the Company; provided, that the Company shall not be
required to provide the Executive an opportunity to cure any breaches of the non-compete and non-solicit pursuant to this Agreement
or any other agreement that the Executive has entered into with the Company or its affiliates.

 

4.2.
By the Company Without Cause. Notwithstanding any other provisions to the contrary contained herein, the Company may terminate
this Agreement without Cause (and other than due to Disability) by giving written notice to the Executive. If the Company terminates
this Agreement without Cause (and other than due to death or Disability) the Company shall provide, in addition to the Accrued
Amounts, severance pay and benefits to the Executive as follows: (i) continued payment of Base Salary during the period immediately
following such termination through one year from the date of termination or, if the termination occurs during the second year
of the term, the expiration of the Term, in substantially equal installments, payable in accordance with the Company's normal
payroll dates; (ii) the Company shall continue to provide coverage during such period following the Executive’s termination
of employment (or until the Executive becomes eligible for comparable coverage under the medical health plans of a successor employer,
if earlier) for the Executive and any eligible dependents under all Company health and welfare plans in which the Executive
and any such dependents participated immediately prior to the date of termination, to the extent permitted thereunder and subject
to any active-employee cost-sharing or similar provisions in effect for the Executive thereunder as of immediately prior to the
date of termination and (iii) the Annual Bonus and Equity Award set forth in Section 3(b)(ii) and Section 3(b)(iii) if the requisite
closing price conditions set forth in such Sections are achieved as of employment termination date. Any payments made to Executive
pursuant to this Section 4(b) shall be subject to the Executive's execution and non-revocation of the Release in accordance with
Section 4(g) below and shall be in lieu of any rights under any severance plan or policy being utilized for or provided to the
Company’s other officers and employees. Reporting of and withholding on any payment under this subsection for tax purposes
shall be at the discretion of the Company in conformance with applicable tax laws.

 

4.3.
Disability. Notwithstanding any other provisions to the contrary contained herein, if the Executive fails to perform his
duties hereunder on account of illness or other incapacity for a period of one hundred twenty (120) consecutive days (or a period
of 150 days in any 365-day period) (“Disability”), the Company shall have the right upon written notice to
the Executive to terminate the Executive’s employment under this Agreement by paying the Executive the Accrued Amounts.
Any of the compensation owed to which the Executive was entitled pursuant to Section 3 above shall remain available through the
period of illness of incapacity until termination of the Executive’s employment under this Agreement.

 

4.4.
Death. Notwithstanding any other provisions to the contrary contained herein, if the Executive dies during the Term, this
Agreement shall terminate immediately, and the Executive’s legal representatives or designated beneficiary shall be entitled
to receive the Accrued Amounts.

 

4.5.
Good Reason. Notwithstanding any other provisions to the contrary contained herein, the Executive may terminate his employment
pursuant to this Agreement for Good Reason by giving thirty (30) days written notice. For purposes of this Agreement, “Good
Reason” shall mean the occurrence of any of the following without the consent of the Executive: (i) a material adverse change
in the Executive’s position, duties, responsibilities or status as an executive officer of the Company with the title set
forth in this Agreement (or such other more senior title conferred upon Executive by the Board); (ii) the Company breaches any
material obligation, duty or agreement under this Agreement; (iii) the Company changes the Executive’s principal place of
employment to a location more than fifty (50) miles from Irvine California; or (iv) the Company materially reduces the Executive’s
Base Salary. No termination by the Executive for Good Reason pursuant to any of the clauses above will be effective unless (A)
the Executive gives timely written notice to the Company specifying in reasonable detail the circumstances claimed to provide
the basis for such termination and does so within thirty (30) days following the initial occurrence of such circumstances, (B)
the Company fails to cure the circumstances set forth in the Executive’s written notice within thirty (30) days of actual
receipt of such notice, and (C) the Executive terminates his employment within thirty (30) days following the end of such cure
period. In the event Executive terminates his employment for Good Reason, Executive shall be entitled to the same payments and
benefits from the Company that he would have been entitled to under Section 4(b) had the Company terminated his employment
without Cause (other than due to Disability).

 

4.6.
By the Executive Without Good Reason. Notwithstanding any other provisions to the contrary contained herein, the Executive
may terminate his employment under this Agreement without Good Reason by giving thirty (30) days written notice, in which event
the Company shall be obligated to pay the Executive only the Accrued Amounts.

 

4.7.
Conditions to Payment. Any severance payments or benefits under Section 4(b) or (e) shall be (i) conditioned upon the Executive
having provided an irrevocable waiver and general release of claims in favor of the Company and its respective affiliates, their
respective predecessors and successors, and all of the respective current or former directors, officers, employees, shareholders,
partners, members, agents or representatives of any of the foregoing (collectively, the “Released Parties”),
in substantially the form attached hereto as Exhibit A (the “Release”), which shall become effective
and irrevocable in accordance with its terms within sixty (60) days following the Executive’s termination of employment
and (ii) subject to the Executive’s continued compliance with the terms of Sections 5, 6 and 7 and (iii) the installment
payments pursuant to Section 4(b)(i) shall commence on the first payroll period following the date that the Release becomes effective,
and the initial installment shall include a lump-sum payment of all amounts accrued under Section 4(b)(i) from the date of termination
through the date of such initial payment.

 

4.8.
Resignations. Upon termination of the Executive’s employment for any reason, and regardless of whether the Executive
continues as a consultant to the Company, upon the Company’s request the Executive agrees to resign, as of the date of such
termination of employment or such other later date requested, from the Board and any committees thereof (and, if applicable, from
the board of directors (and any committees thereof) of any subsidiary or affiliate of the Company) to the extent the Executive
is then serving thereon, and Executive agrees to promptly execute any documents reasonably required to effectuate the foregoing.

 

4.9.
Treatment of Employee Benefits; Offset. The payment of any amounts accrued under any benefit plan, program or arrangement
in which the Executive participates shall be subject to the terms of the applicable plan, program or arrangement, and any elections
the Executive has made thereunder. The Company may offset any amounts due and payable by the Executive to the Company or its subsidiaries
against any amounts the Company owes the Executive hereunder.

 

5.
Covenants of the Executive. For purposes of this Section 5, and Sections 6 and 7, references to the Company shall include
its subsidiaries and affiliates. For purposes of this Agreement, “affiliates” means all persons and entities
directly or indirectly controlling, controlled by or under common control with the Company, where control may be by either management
authority or equity interest.

 

5.1.
Confidentiality. The Executive acknowledges that in his capacity as an executive of the Company he will occupy a position
of trust and confidence, and he further acknowledges that he will have access to and learn substantial information about the Company
and its operations that is confidential or not generally known in the industry including, without limitation, information that
relates to the Company’s purchasing, sales, customers, marketing, financial position and financing arrangements. The Executive
agrees that all such information is proprietary or confidential or constitutes trade secrets and is the sole property of the Company.
Accordingly, during the Executive’s employment by the Company and thereafter, the Executive will keep confidential, and
will not without the Company’s prior written consent reproduce, copy or disclose to any other person or firm, or use for
the Executive’s own purposes, any such information or any documents or information relating to the Company’s methods,
processes, customers, accounts, analyses, systems, charts, programs, procedures, correspondence, or records, or any other documents
used or owned by the Company (“Confidential Information”), nor will the Executive advise, discuss with or in
any way assist any other person or firm in obtaining or learning about any Confidential Information, either alone or with others:
provided, however, that the Executive shall be permitted to disclose any information (i) to his counsel or accountants
who reasonably need to know such information for purposes of advising Executive with respect to his investment in the Company
or (ii) in connection with enforcing his rights under this Agreement or any other agreement with the Company; provided,
further, that the Executive shall be permitted, while employed by the Company, to disclose any information solely to the
extent necessary, in the good faith judgment of the Executive, to fulfill the Executive’s employment obligations with respect
to the Company. Notwithstanding the foregoing, if the Executive receives a request to disclose Confidential Information pursuant
to a deposition, interrogation, request for information or documents in legal proceedings, subpoena, civil investigative demand,
governmental or regulatory process or similar process, (i) the Executive shall promptly notify in writing the Company, and consult
with and assist the Company in seeking a protective order or request for other appropriate remedy, (ii) in the event that such
protective order or remedy is not obtained, or if the Company waives compliance with the terms hereof, the Executive shall disclose
only that portion of the Confidential Information which, in the written opinion of the Executive’s legal counsel, is legally
required to be disclosed and shall exercise reasonable best efforts to provide that the receiving person or entity shall agree
to treat such Confidential Information as confidential to the extent possible (and permitted under applicable law) in respect
of the applicable proceeding or process, and (iii) the Company shall be given an opportunity to review the Confidential Information
prior to disclosure thereof. Notwithstanding the Executive’s obligations in this Agreement and otherwise, the Executive
understands that, as provided by the Federal Defend Trade Secrets Act, the Executive will not be held criminally or civilly liable
under any federal or state trade secret law for the disclosure of a trade secret made: (1) in confidence to a federal, state,
or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating
a suspected violation of law; or (2) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is
made under seal.

 

5.2.
Noncompetition; Nonsolicitation; Nondisparagement.

 

5.2.1.
Acknowledgement. The Executive acknowledges that during the Executive’s employment with the Company, the Executive
has and will become familiar with the Company’s trade secrets and with other Confidential Information concerning the Company
and that the Executive’s services have been and will be of special, unique and extraordinary value to the Company. Therefore,
and in further consideration of the compensation to be paid to the Executive hereunder the Executive agrees to the covenants set
forth in this Section 5(b) and acknowledges that (i) the covenants set forth in this Section 5(b) are reasonably limited in time
and in all other respects, (ii) the covenants set forth in this Section 5(b) are reasonably necessary for the protection
of the Company, and (iii) the covenants set forth in this Section 5(b) have been made in order to induce the Company to enter
into this Agreement and the Company would not have entered into this Agreement but for the Executive’s agreement to such
covenants.

 

5.2.2.
Noncompete. The Executive agrees that, during the period the Executive is employed with the Company, the Executive shall
not (and shall cause his affiliates not to) directly or indirectly, on behalf of the Executive or any third party, own any interest
in, manage, control, participate in, consult with, contribute to, or render services for, any corporation, partnership, person,
firm, or other entity that is engaged in business which is competitive with the Company’s products and services.

 

5.2.3.
Employee Nonsolicit. During the Term and for eighteen (18) months thereafter (the “Non-Solicitation Period”),
the Executive shall not (and shall cause his affiliates not to) directly, or indirectly, on behalf of the Executive or any third
party (i) solicit or induce or attempt to solicit or induce any employee of the Company to leave the employ of the Company, or
in any way interfere with the relationship between the Company and any employee thereof, or (ii) hire any person who was an employee
of the Company at any time during the one-year period preceding the date of termination of the Executive’s employment with
the Company, the Executive may, solely in connection with any business that is not a competing business, hire, employ, engage
or contract to perform services with any family member of the Executive who is not then employed by the Company or any of its
Subsidiaries (provided that, for the avoidance of doubt, this clause (ii) shall not permit the Executive to solicit, entice, encourage
or intentionally influence, or attempt to solicit, entice, encourage or influence any family member to resign or otherwise voluntarily
terminate his or her employment with the Company or its Subsidiaries).

 

5.2.4.
Customer Nonsolicit. During the Term and for eighteen months thereafter, the Executive shall not (and shall cause his affiliates
not to) directly, or indirectly, on behalf of the Executive or any third party (i) make any statement or do any act intended to
cause existing or potential customers of the Company to make use of the services or purchase the products of any competitive business
or (ii) induce or attempt to induce any customer, supplier, licensee, licensor, franchisee or other business relation of the Company
to cease doing business with, or materially and adversely change the terms of its business with, the Company, or in any way interfere
with the relationship between any such customer, supplier, licensee, licensor, franchisee or business relation and the Company
(including, without limitation, making any negative statements or communications about the Company).

 

5.2.5.
Nondisparagement. During the Term and for three years thereafter, the Executive and the Company agree not to make (and
shall cause its affiliates not to make) any derogatory statement or communication about the other party or any of the other party’s
current or former directors, officers, employees, shareholders, partners, members, agents, products and services. The foregoing
shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative
or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).

 

5.3.
Enforcement. If, at the time of enforcement of Section 5 of this Agreement, a court holds that the restrictions stated
herein are unreasonable under circumstances then existing, the parties hereto agree that the maximum time period, scope or geographical
area reasonable under such circumstances shall be substituted for the stated time period, scope or geographical area. The refusal
or failure of the Company or its successors or assigns to enforce any of the restrictive covenants set forth in Section 5 against
the Executive, for any reason, shall not constitute an act of precedent or a defense to the enforcement by the Company or its
successors or assigns of the restrictive covenants set forth herein. In addition, in the event a court of competent jurisdiction
determines that a breach or violation by the Executive of Section 5(b)(ii) or 5(b)(iii) has occurred, the Non-Solicitation Period
shall be tolled until such breach or violation has been duly cured. The Executive agrees that the restrictions contained in Section
5 of this Agreement are reasonable. Each of the Company and the Executive agrees that the covenants made in Section 5 shall be
construed as independent of any other provision in this Agreement and shall survive any order of a court of competent jurisdiction
terminating any other provision of this Agreement and be deemed to be a series of separate covenants.

 

5.4.
Remedy for Breach. The Executive acknowledges that the Company will be irrevocably damaged if all of the provisions of
this Section 5 are not specifically enforced, and that any remedy at law (including the payment of damages) would be inadequate.
Accordingly, the Executive agrees that, in addition to any other legal or equitable relief to which the Company may be entitled,
the Company will be entitled (without the necessity of showing economic loss or other actual damage) to seek and obtain injunctive
relief from a court of competent jurisdiction for the purpose of restraining the Executive from any actual breach of this Section 5.
The preceding sentence shall not be construed as a waiver of the rights that the Company may have for damages under this Agreement
or otherwise, and all of the Company’s rights shall be unrestricted. The parties’ obligations under this Section 5
shall survive the Executive’s termination of employment with the Company for the periods of time specified in Section 5.

 

5.5.
Whistleblower Exception. Notwithstanding anything to the contrary contained herein, nothing in this Agreement shall prohibit
the Executive from reporting possible violations of federal law or regulation to or otherwise cooperating with or providing information
requested by any governmental agency or entity, including, but not limited to, the Department of Justice, the Securities
and Exchange Commission, the United States Congress, any state legislative and executive agency, and any agency Inspector General,
or making other disclosures that are protected under the whistleblower provisions of federal law or regulation. The Executive
does not need the prior authorization of the Company to make any such reports or disclosures and the Executive is not required
to notify the Company that the Executive has made such reports or disclosures.

 

6.
Return of Property. Upon termination of the Executive’s employment under this Agreement, the Executive shall return
immediately to the Company all notes, memoranda, records, documents, computer, software or intellectual property or any other
property, in whatever form (including electronic), of or pertaining to the Company and shall not make or retain any copy or extract
of any of the foregoing.

 

7.
Improvements and Inventions. Any and all improvements or inventions or ideas, and any other tangible or intangible property
which the Executive may conceive, develop, learn, make or participate in or reduce to practice during the period of his employment
and in connection with this employment that relate to the Company’s business, and any works-in-progress, shall be deemed
works-made-for-hire and are the sole and exclusive property of the Company. The Executive will, whenever requested by the Company
during the period of his employment and thereafter, execute and deliver any and all documents which the Company shall deem appropriate
in order to apply for and obtain patents for improvements or inventions or in order to assign and convey to the Company the sole
and exclusive right, title and interest in and to such improvements, inventions, ideas and other tangible and intangible property
(including patents or applications therefor). The Executive hereby waives and quitclaims to the Company any and all claims
of any nature whatsoever that the Executive now or may hereafter have for infringement of any proprietary rights assigned
hereunder to the Company.

 

8.
Cooperation. The Executive agrees that, upon reasonable notice and without the necessity of the Company obtaining a subpoena
or court order but subject to the advice of the Executive’s legal counsel, the Executive shall provide reasonable cooperation
in connection with any suit, action or proceeding (or any appeal from any suit, action or proceeding), and any investigation and/or
defense of any claims asserted against any Released Parties, which relates to events occurring during the Executive’s employment
with the Company and its subsidiaries and affiliates as to which the Executive may have relevant information (including but not
limited to furnishing relevant information and materials to the Company or its designee and/or providing testimony at depositions
and at trial), provided that with respect to such cooperation occurring following termination of employment, the Company shall
reimburse the Executive for expenses reasonably incurred in connection therewith and, subject to the Company's prior written approval,
the Company will reimburse reasonable and documented legal expenses, to the extent reasonably necessary in connection with the
requested cooperation. Any such cooperation occurring after the termination of the Executive’s employment shall be scheduled
to the extent reasonably practicable so as not to unreasonably interfere with the Executive’s business or personal affairs.

 

9.
Miscellaneous.

 

9.1.
Entire Agreement; Amendment. This Agreement constitutes the entire agreement between the parties with respect to the Executive’s
employment with the Company and supersedes any and all prior or contemporaneous agreements or understandings, whether oral or
written, relating to such employment. None of the parties shall be liable or bound to any other party in any manner by any representations
and warranties or covenants relating to such subject matter except as specifically set forth herein. This Agreement may be amended,
modified, supplemented, or changed only by a written document signed by the Executive and a duly authorized officer of the Company
(other than the Executive).

 

9.2.
Notices. Any notice, request, communication or instruction to be given hereunder shall be in writing and shall be delivered
by hand or sent by email or by postage prepaid, registered, certified or express mail or by overnight courier service and shall
be deemed given when so delivered by hand or email, or if mailed by registered or certified mail, three days after mailing (one
business day in the case of express mail or overnight courier service) to the parties at the following addresses (or at such other
address for a party as shall be specified by like notice):

 

	To the Company:	Mountain High Acquisitions Corp
	 	Attn: Chief Executive Officer
	 	4350 Executive Drive, Suite 200 San Diego CA 92121
	 	 
	 	With a copy to (which shall not constitute notice):
	 	 
	 	TroyGould PC
	 	1801 Century Park East, Suite 1600
	 	Los Angeles, CA 90067
	 	Attn: David L. Ficksman, Esq.
	 	 
	 	 
	To the Executive:	At the last known address on the Company’s records. 

 

9.3.
No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not
be considered a waiver thereof or deprive that party of the right thereafter to insist upon strict adherence to that term or any
other term of this Agreement. No failure or delay by either party in exercising any right or power hereunder will operate as a
waiver thereof, nor will any single or partial exercise of any such right or power, or any abandonment of any steps to enforce
such a right or power, preclude any other or further exercise thereof or the exercise of any other right or power.

 

9.4.
Assignment. This Agreement is personal to the Executive and without the prior written consent of the Company shall not
be assignable by the Executive, except for the assignment by will or the laws of descent and distribution of any accrued pecuniary
interest of the Executive, and any assignment in violation of this Agreement shall be void. This Agreement shall be binding on,
and shall inure to the benefit of, the parties to it and their respective heirs, legal representatives, successors and permitted
assigns (including, without limitation, in the event of the Executive’s death, the Executive’s estate and heirs in
the case of any payments due to the Executive hereunder). The Executive acknowledges and agrees that all of the Executive’s
covenants and obligations to the Company, as well as the rights of the Company hereunder, shall run in favor of and shall be enforceable
by the Company and its successors and assigns. The Company may assign this Agreement and its rights and obligations hereunder
to any affiliate or any entity which, by way of merger, consolidation, purchase or otherwise, becomes, directly or indirectly,
a successor to all or substantially all of the business and/or assets of the Company.

 

9.5.
Governing Law. This Agreement shall be deemed to be made in the State of California, and the validity, interpretation,
construction, and performance of this Agreement in all respects shall be governed by the laws of the State of California without
regard to its principles of conflicts of law. No provision of this Agreement or any related document will be construed against
or interpreted to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such
party having or being deemed to have structured or drafted such provision.

 

9.6.
Consent to Jurisdiction; Waiver of Jury Trial. 9.6.1. Except as otherwise specifically provided herein, the Executive and
the Company each hereby irrevocably submits to the exclusive jurisdiction of the federal District Courts sitting in Los Angeles
California (or, if subject matter jurisdiction in such courts is not available, in any state court located in the State of California)
over any dispute arising out of or relating to this Agreement. Except as otherwise specifically provided in this Agreement, the
parties undertake not to commence any suit, action or proceeding arising out of or relating to this Agreement in a forum other
than a forum described in this Section 9(f)(i); provided, however, that nothing herein shall preclude the Company
from bringing any suit, action or proceeding in any other court for the purposes of enforcing the provisions of this Section 9(f)
or enforcing any judgment obtained by the Company.

 

A.
The agreement of the parties to the forum described in Section 9(f)(i) is independent of the law that may be applied in any suit,
action, or proceeding and the parties agree to such forum even if such forum may under applicable law choose to apply non-forum
law. The parties hereby waive, to the fullest extent permitted by applicable law, any objection which they now or hereafter have
to personal jurisdiction or to the laying of venue of any such suit, action or proceeding brought in an applicable court described
in Section 9(f)(i), and the parties agree that they shall not attempt to deny or defeat such personal jurisdiction by motion or
other request for leave from any such court. The parties agree that, to the fullest extent permitted by applicable law, a final
and non-appealable judgment in any suit, action or proceeding brought in any applicable court described in Section 9(f)(i) shall
be conclusive and binding upon the parties and may be enforced in any other jurisdiction.

 

B.
  Each party hereto hereby waives, to the fullest extent permitted by applicable law, any right it may have to a trial by
jury in respect of any suit, action or proceeding arising out of or relating to this Agreement. Each party hereto (A) certifies
that no representative, agent or attorney of any other party has represented, expressly or otherwise, that such party would not,
in the event of any action, suit or proceeding, seek to enforce the foregoing waiver and (B) acknowledges that it and the other
party hereto has been induced to enter into this Agreement by, among other things, the mutual waiver and certifications in this
Section 9(f)(iii). The prevailing party in any suit, action or proceeding arising out of or related to this Agreement may obtain
an award to recover his or its costs and expenses (including reasonable attorneys’ fees and expenses) incurred in connection
with any dispute arising out of or relating to this Agreement.

 

9.7.
Withholding. The Company may deduct and withhold from any amounts payable under this Agreement such Federal, state, local,
non-U.S. or other taxes as are required or permitted to be withheld pursuant to any applicable law or regulation.

 

9.8.
Representations of the Executive. The Executive represents, warrants and covenants that as of the date hereof and as of
the Effective Date: (i) the Executive has the full right, authority and capacity to enter into this Agreement and perform the
Executive’s obligations hereunder, (ii) the Executive is not bound by any agreement that conflicts with or prevents or restricts
the full performance of the Executive’s duties and obligations to the Company hereunder during or after the Term and (iii)
the execution and delivery of this Agreement shall not result in any breach or violation of, or a default under, any existing
obligation, commitment or agreement to which the Executive is subject.

 

9.9.
Section 409A Compliance. It is intended that the provisions of this Agreement comply with Section 409A of the Internal
Revenue Code, as amended (the “Code”), and all provisions of this Agreement will be construed and interpreted
in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A of the Code. The Company cannot
make any representations or guarantees with respect to compliance with such requirements, and neither the Company nor any affiliate
will have any obligation to indemnify the Executive or otherwise hold him harmless from any or all of such taxes or penalties.
For purposes of Section 409A of the Code, each installment payment hereunder will be deemed a “separate payment” within
the meaning of Treas. Reg. Section 1.409A-2(b)(iii). With respect to the timing of payments of any deferred compensation payable
upon a termination of employment hereunder, references in this Agreement to “termination of employment” (and substantially
similar phrases) mean “separation from service” within the meaning of Section 409A of the Code. For the avoidance
of doubt, it is intended that any expense reimbursement made to the Executive hereunder is exempt from Section 409A of the Code;
however, if any expense reimbursement hereunder is determined to be deferred compensation within the meaning of Section 409A of
the Code, then (i) the amount of the expense reimbursement during one taxable year will not affect the amount of the expense reimbursement
during any other taxable year, (ii) the expense reimbursement will be made on or before the last day of the year following the
year in which the expense was incurred, and (iii) the right to expense reimbursement hereunder will not be subject to liquidation
or exchange for another benefit. If the sixty day period following the date of termination of employments ends in the calendar
year following the year that includes the date of termination of employment, then payment of any amount that is conditioned upon
the execution of the release of claims described in Section 4(g) above and is subject to Section 409A shall not be paid until
the first day of the calendar year following the year that includes the date of termination of employment, regardless of when
the release is signed.

 

9.10.
Advice of Counsel. Prior to execution of this Agreement, the Executive was advised by the Company of the Executive’s
right to seek independent advice from an attorney of the Executive’s own selection regarding this Agreement. The Executive
acknowledges that the Executive has entered into this Agreement knowingly and voluntarily and with full knowledge and understanding
of the provisions of this Agreement after being given the opportunity to consult with counsel. The Executive further represents
that in entering into this Agreement, the Executive is not relying on any statements or representations made by any of the Company’s
directors, officers, employees or agents which are not expressly set forth herein, and that the Executive is relying only upon
the Executive’s own judgment and any advice provided by the Executive’s attorney. For the avoidance of doubt, the
Executive acknowledges and agrees that the Executive has read the Agreement in its entirety, and has been represented by independent
legal counsel in negotiating the terms of this Agreement, including, but not limited to, the California choice of law and California
choice of forum provisions, and the restrictive covenants contained herein.

 

9.11.
Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by
a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances
other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision
of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

 

9.12.
Survival. The rights and obligations of the parties under the provisions of this Agreement shall survive, and remain binding
and enforceable, notwithstanding the expiration of the Term, the termination of this Agreement, the termination of the Executive’s
employment hereunder or any settlement of the financial rights and obligations arising from the Executive’s employment hereunder.

 

9.13.
Captions and Headings. The captions and headings are for convenience of reference only and shall not be used to construe
the terms or meaning of any provisions of this Agreement. When a reference in this Agreement is made to a Section, such reference
shall be to a Section of this Agreement unless otherwise indicated.

 

9.14.
Counterparts. This Agreement may be executed in one or more counterparts (including via facsimile and electronic image
scan (pdf)), each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument
and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties.

 

 

[EXECUTIONS
COMMENCE NEXT PAGE]

    	 

    	 

    

IN
WITNESS WHEREOF, the parties have duly executed this Employment Agreement as of the date set forth above.

 

THE COMPANY

 

By: _____________________________

Name:
Raymond Watt

Title:
Chief Executive Officer

 

EXECUTIVE

 

By: _____________________________

DAVID
AQUINO

 

    	 

    	 

    

Exhibit
A

WAIVER
AND RELEASE OF CLAIMS

 

In
connection with the termination of employment of DAVID AQUINO (the “Executive”) pursuant to the employment
agreement (the “Employment Agreement”), dated as of March 8, 2021, between the Executive and Mountain
High Acquisitions Corp., a Colorado corporation (together with any of its subsidiaries and affiliates as may have employed the
Executive from time to time, and any and all successors thereto, the “Company”), the Executive agrees
as follows:

 

1. Release
of Claims. In partial consideration of the payments and benefits described in Section 4(b) of the Employment
Agreement, to which the Executive agrees that the Executive is not entitled until and unless the Executive executes this
waiver and release of claims (this “Release”) and it becomes effective in accordance with the terms hereof,
the Executive, for and on behalf of the Executive and the Executive’s heirs, beneficiaries, devisees, executors, administrators,
attorneys, personal representatives, successors and assigns, subject to the last sentence of this Section 1, hereby waives and
releases any common law, statutory or other complaints, claims, charges or causes of action of any kind whatsoever, both known
and unknown, in law or in equity, fixed or contingent, asserted or unasserted, apparent or concealed, which the Executive ever
had, now has or may have against the Company, and their former, present or future shareholders, parents, subsidiaries, affiliates,
predecessors, successors, assigns, directors, officers, partners, members, managers, employees, trustees (in their official and
individual capacities), employee benefit plans and their administrators and fiduciaries (in their official and individual capacities),
representatives or agents and each of their affiliates, successors and assigns (collectively, the “Releasees”),
by reason of facts or omissions which have occurred on or prior to the date that the Executive signs this Release related to Executive’s
employment or termination of employment, including, without limitation, any complaint, charge or cause of action arising out of
the Executive’s employment or termination of employment, or any term or condition of that employment, or arising under federal,
state, local or foreign laws pertaining to employment, including, without limitation, the Age Discrimination in Employment Act
of 1967 (“ADEA,” a law which prohibits discrimination on the basis of age), the Older Workers Benefit Protection
Act, the National Labor Relations Act, the Civil Rights Act of 1991, the Americans With Disabilities Act of 1990, Title VII of
the Civil Rights Act of 1964, the Employee Retirement Income Security Act of 1974, the Family and Medical Leave Act, the California
Fair Employment and Housing Act, California Labor Code Section 200 et seq., and any applicable California Industrial Welfare
Commission order, all as amended, and any other federal, state and local laws relating to discrimination on the basis of age,
sex or other protected class, all claims under federal, state or local laws for express or implied breach of contract, wrongful
discharge, defamation, intentional infliction of emotional distress, and any related claims for attorneys’ fees and costs.
The Executive further agrees that this Release may be pleaded as a full defense to any action, suit, arbitration or other proceeding
covered by the terms hereof which is or may be initiated, prosecuted or maintained by the Executive, the Executive’s descendants,
dependents, heirs, executors, administrators or permitted assigns. By signing this Release, the Executive acknowledges that the
Executive intends to waive and release any rights known or unknown that the Executive may have against the Releasees under these
and any other laws; provided that the Executive does not waive or release claims with respect to (i) any rights the Executive
may have to the payments and benefits under Section 4(b) or 4(e) of the Employment Agreement, (ii) any claims or rights to indemnification
under applicable law or any agreement with any Releasee; (iii) rights to any restricted shares of the Company’s Common Stock
or other equity interest in the Company; (iv) rights under the Exchange Agreement; (v) rights to any vested benefits under the
Company’s employee benefit plans; and (iv) rights that cannot be released as a matter of law (collectively, the “Unreleased
Claims”). The Executive hereby waives any and all claims to reemployment with the Company or any of its affiliates and
affirmatively agrees not to seek further employment with the Company or any of its affiliates.

 

If
the Executive has worked or is working in California, the Executive expressly agrees to waive the protection of Section 1542 of
the California Civil Code, which provides:

 

A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER
FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND THAT IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT
WITH THE DEBTOR OR RELEASED PARTY.

 

2. Proceedings.
The Executive acknowledges that the Executive has not filed any complaint, charge, claim or proceeding against any of the Releasees
before any local, state, federal or foreign agency, court, arbitrator, mediator, arbitration or mediation panel or other body
(each individually, a “Proceeding”). The Executive represents that the Executive is not aware of any basis
on which such a Proceeding could reasonably be instituted. The Executive (i) acknowledges that the Executive shall not initiate
or cause to be initiated on the Executive’s behalf any Proceeding (except with respect to an Unreleased Claim) and shall
not participate in any Proceeding (except with respect to an Unreleased Claim), in each case, except as required by law, (ii)
represents and warrants that neither the Executive nor anyone on the Executive’s behalf has filed or joined in any such
Proceeding against the Releasees or has pledged, assigned, sold or otherwise transferred, in whole or in part, any such claims
and (iii) waives any right the Executive may have to benefit in any manner from any relief (whether monetary or otherwise) arising
out of any Proceeding, including any Proceeding conducted by the Equal Employment Opportunity Commission (“EEOC”).
Further, the Executive understands that, by executing this Release, Executive shall be limiting the availability of certain remedies
that the Executive may have against the Company and limiting also the ability of the Executive to pursue certain claims against
the Releasees. Notwithstanding the above, nothing in Section 1 of this Release shall prevent the Executive from (a) initiating
or causing to be initiated on the Executive’s behalf any complaint, charge, claim or proceeding against the Company before
any local, state or federal agency, court or other body challenging the validity of the waiver of the Executive’s claims
under ADEA contained in Section 1 of this Release (but no other portion of such waiver); or (b) initiating or participating in
an investigation or proceeding conducted by the EEOC.

 

3. Time
to Consider. The Executive acknowledges that the Executive has been advised that the Executive has [twenty-one (21)][forty-five
(45)] days from the date of receipt of this Release to consider all the provisions of this Release and to the extent the Executive
signs this Release prior to the expiration of such period the Executive does hereby knowingly and voluntarily waive the remaining
portion of such [twenty-one (21)][forty-five (45)] day period. THE EXECUTIVE FURTHER ACKNOWLEDGES THAT THE EXECUTIVE HAS READ
THIS RELEASE CAREFULLY, HAS BEEN ADVISED BY THE COMPANY TO, AND HAS IN FACT, CONSULTED AN ATTORNEY AND FULLY UNDERSTANDS THAT
BY SIGNING BELOW THE EXECUTIVE IS GIVING UP CERTAIN RIGHTS WHICH THE EXECUTIVE MAY HAVE TO SUE OR ASSERT A CLAIM AGAINST ANY OF
THE RELEASEES, AS DESCRIBED IN SECTION 1 OF THIS RELEASE AND THE OTHER PROVISIONS HEREOF. THE EXECUTIVE ACKNOWLEDGES THAT THE
EXECUTIVE HAS NOT BEEN FORCED OR PRESSURED IN ANY MANNER WHATSOEVER TO SIGN THIS RELEASE, AND THE EXECUTIVE AGREES TO ALL OF ITS
TERMS VOLUNTARILY.

 

4. Revocation.
The Executive hereby acknowledges and understands that the Executive shall have seven (7) days from the date of execution of this
Release to revoke this Release (including, without limitation, any and all claims arising under ADEA) and that neither the Company
nor any other person is obligated to provide any payments or benefits to the Executive pursuant to the Employment Agreement until
eight (8) days have passed since the Executive’s signing of this Release without the Executive having revoked this Release
(such eighth (8th) day, on which the Release becomes irrevocable and effective, the “Release Effective Date”).
If the Executive revokes this Release, the Executive shall be deemed not to have accepted the terms of this Release, and no action
shall be required of the Company under any section of this Release. Any revocation of this Release must be made in writing and
delivered to the Company in accordance with Section 9(b) of the Employment Agreement.

 

5. No
Admission; Confidentiality. This Release does not constitute an admission of liability or wrongdoing of any kind by the Executive
or the Company. Except as expressly set forth otherwise in this Release, the Executive agrees that the Executive shall not disclose
the terms of this Release, except to the Executive’s immediate family and the Executive’s financial and legal counsel
and advisors or as may be required by law or ordered by a court. The Executive further agrees that any disclosure to the Executive’s
financial and legal counsel and advisors shall only be made after such counsel and advisors acknowledge and agree to maintain
the confidentiality of this Agreement and its terms.

 

6. General
Provisions. The provisions of this Release shall be binding upon the Executive’s heirs, executors, administrators, legal
representatives and assigns. A failure of any of the Releasees to insist on strict compliance with any provision of this Release
shall not be deemed a waiver of such provision or any other provision hereof. If any provision of this Release is determined to
be so broad as to be unenforceable, such provision shall be interpreted to be only so broad as is enforceable, and in the event
that any provision is determined to be entirely unenforceable, such provision shall be deemed severable, such that all other provisions
of this Release shall remain valid and binding upon the Executive and the Releasees.

 

7. Governing
Law. The validity, interpretations, construction and performance of this Release shall be governed by the laws of the State
of California without giving effect to conflict of laws principles. By execution of this Release, the Executive waives any right
to trial by jury in connection with any suit, action or proceeding under or in connection with this Release. The Executive hereby
represents that Executive was represented by counsel and expressly agrees to all the provisions in this Agreement, including,
without limitation, this Section 7.

 

 

[Remainder
of Page Intentionally Left Blank]

    	 

    	 

    

IN
WITNESS WHEREOF, the Executive has executed and delivered this Release as of the date written below.

 

 

 

	________________________       	__________________________
	DATE	DAVID AQUINO

 

 

Not
to be executed until termination of employmentExhibit
10.1 

 

2021
EMPLOYEES/CONSULTANTS STOCK COMPENSATION PLAN

 

OF

 

4DMED,
LTD.

 

SECTION
1.

ESTABLISHMENT
AND PURPOSE

 

This
2021 Employees/Consultants Stock Company Plan of 4DMed, Ltd. (the “PLAN”) is hereby established January 25, 2021,
effective January 25, 2021 (the “EFFECTIVE DATE”), to offer directors, officers and selected key employees, advisors
and consultants an opportunity to acquire a proprietary interest in the success of the Company to receive compensation, or to
increase such interest, by purchasing shares of the Company’s common stock (“SHARES”). Except as otherwise expressly
provided herein, this instrument contains the provisions of the Plan. The Plan provides both for the direct award or sale of Shares
and for the grant of Options to purchase Shares. Options granted under the Plan may include non-statutory options intended to
meet the requirements for exclusion from coverage under section 409A of the Code, as well as ISOs intended to qualify under section
422 of the Code. All Options granted hereunder shall be interpreted in a manner consistent with these intentions.

 

The
Plan is intended to comply in all respects with Rule 16b-3 (or its successor) under the Exchange Act and shall be construed accordingly. All
transactions involving any Employee subject to section 16(a) of the Exchange Act shall be subject to the conditions set forth
in Rule 16b-3, regardless of whether such conditions are expressly set forth in this Plan. Any provision of this Plan that is
contrary to Rule 16b-3 does not apply to such Employees.

 

SECTION
2.

DEFINITIONS.

 

(A)    “BOARD
OF DIRECTORS” shall mean the Board of Directors of the Company, as constituted from time to time.

 

(B)     “CODE”
shall mean the Internal Revenue Code of 1986, as amended.

 

(C)     “COMMITTEE”
shall mean a committee of the Board of Directors, as described hereinafter. The Plan shall be administered by the Committee of
not less than three Outside Directors who are appointed by the Board of Directors and serve at its pleasure. Unless otherwise
determined by the Board of Directors, the Compensation Committee shall serve as the Committee, and all of the members of the Committee
shall be Outside Directors. The term “Outside Director” shall mean a member of the Board of Directors who meets the
definitions of the terms “outside director” set forth in section 162(m) of the Code, “independent director”
set forth in the rules of a stock exchange on which the Shares may then be listed, and “Non-Employee Director” set
forth in Rule 16b-3 under the Exchange Act, or any successor definitions adopted by the Internal Revenue Service, an applicable
exchange and the Securities and Exchange Commission, respectively, and similar requirements under any other applicable laws and
regulations.

 

(D)     “COMPANY”
shall mean 4DMed, Ltd., a Nevada corporation and any successor corporation or business organization which shall assume the
duties and obligations of 4DMed, Ltd. under this Plan. The term “SUBSIDIARY” shall mean (i) with respect to grants
of ISOs any corporation and any other entity considered a subsidiary as defined in section 424(f) of the Code of the Company,
and (ii) with respect to grants of Non-statutory Options, any entity directly or indirectly controlled by the Company or any entity,
including an acquired entity, in which the Company has a controlling interest (as defined in Treasury Regulation §1.409A-1(b)(5)(iii)),
as determined by the Committee, in its sole discretion, provided such entity is considered a service recipient (within the meaning
of section 409A of the Code) that may be aggregated with the Company.

 

(E)      “EMPLOYEE”
shall mean (i) any individual who is a common-law employee of the Company or of a Subsidiary, (ii) an Outside Director, (iii)
an independent contractor who performs services for the Company or a Subsidiary and who is not a member of the Board of Directors,
including consultants and advisors that provide professional, technical, financial, legal, accounting, capital markets related
and other services. The performance of services as an Outside Director or independent contractor shall be treated as “employment”
for all purposes of the Plan, except as provided in Subsections (A) and (B) of Section 4.

    -1- 

     

    

(F)     “EXCHANGE
ACT” shall mean the Securities Exchange Act of 1934, as amended.

 

(G)     “EXERCISE
PRICE” shall mean the amount for which one Share may be purchased upon exercise of an Option, as specified by the Committee
in the applicable Stock Option Agreement.

 

(H)     “FAIR
MARKET VALUE” shall mean the market price of a Share, determined by the Committee as follows:

 

(i)       If
Shares were traded on a stock exchange on the date in question, then the Fair Market Value shall be equal to the closing price
reported for such date by the applicable composite-transactions report;

 

(ii)      If
Shares were traded over-the-counter on the date in question and was traded on the Nasdaq system or the Nasdaq National Market,
then the Fair Market Value shall be equal to the last transaction price quoted for such date by the Nasdaq system or the Nasdaq
National Market;

 

(iii)     If
Shares were traded over-the-counter on the date in question but was not traded on the Nasdaq system or the Nasdaq National Market,
then the Fair Market Value shall be equal to the mean between the last reported representative bid and asked prices quoted for
such date by the principal automated inter-dealer quotation system on which Shares are quoted or, if the Shares are not quoted
on any such system, by the “Pink Sheets” published by the National Quotation Bureau, Inc.; and

 

(iv)    If
none of the foregoing provisions is applicable, then the Fair Market Value shall be determined by the Committee in good faith
on such basis as it deems appropriate.

 

Notwithstanding
the foregoing, as of any date in question, the “Fair Market Value” of a Share shall be determined in a manner consistent
with section 409A of the Code, except that a Share subject to an ISO shall be determined in a manner consistent with section 422
of the Code. In all cases, the determination of Fair Market Value by the Committee shall be conclusive and binding on all persons.

 

(I)       “ISO”
shall mean a stock option that is clearly identified as such and which meets the requirements of section 422 of the Code. Any
ISO which fails to comply with section 422 of the Code for any reason shall automatically be treated as a Non-statutory Option
appropriately granted under this Plan provided it otherwise meets the Plan’s requirements for Non-statutory Options.

 

(J)      “NON-STATUTORY
OPTION” shall mean a stock option that is governed by section 83 of the Code and is not described in sections 422 or 423
of the Code.

 

(K)     “OFFEREE”
shall mean an individual to whom the Committee has offered the right to acquire Shares under the Plan (other than upon exercise
of an Option)

 

(L)     “OPTION”
shall mean an ISO or Non-statutory Option granted under the Plan and entitling the holder to purchase Shares.

 

(M)    “OPTIONEE”
shall mean an individual who holds an Option.

 

(N)     “OUTSIDE
DIRECTOR” shall mean a member of the Board of Directors who is not a common-law employee of the Company or of a Subsidiary.

 

(O)     COMMITTEE
PROCEDURES. The Committee shall designate one of its members as chairman. The Committee may hold meetings at such times and places
as it shall determine. The acts of a majority of the Committee members present at meetings at which a quorum exists, or acts reduced
to or approved in writing by all Committee members, shall be valid acts of the Committee.

    -2- 

     

    

(P)     COMMITTEE
RESPONSIBILITIES. Subject to the provisions of the Plan, the Committee shall have the authority and discretion to take the following
actions:

 

(i)       To
interpret the Plan, any Stock Purchase Agreement and any Stock Option Agreement and to apply their provisions;

 

(ii)      To
adopt, amend or rescind rules, procedures and forms relating to the Plan;

 

(iii)     To
authorize any person to execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan;

 

(iv)     To
determine when Shares are to be awarded or offered for sale and when Options are to be granted under the Plan;

 

(v)      To
select the Offerees and Optionees;

 

(vi)     To
determine the number of Shares to be awarded or offered to each Offeree or to be made subject to each Option;

 

(vii)    To
prescribe the terms and conditions of each award or sale of Shares, including (without limitation) the purchase price, and to
specify the provisions of the Stock Purchase Agreement relating to such award or sale;

 

(viii)   To
prescribe the terms and conditions of each Option, including (without limitation) the Exercise Price, to determine whether such
Option is to be classified as an ISO or as a Non-statutory Option, and to determine the terms and conditions, not inconsistent
with the terms of the Plan, of the Stock Option Agreement relating to such Option;

 

(ix)     To
amend any outstanding Stock Purchase Agreement or Stock Option Agreement, subject to applicable legal restrictions and, to the
extent such amendments are material and adverse to the Offeree’s or Optionee’s interest, obtain the consent of the
Offeree or Optionee who entered into such agreement;

 

(x)      To
prescribe the consideration for the grant of each Option or other right under the Plan and to determine the sufficiency of such
consideration; and

 

(xi)     To
take any other actions deemed necessary or advisable for the administration of the Plan.

 

All
decisions, interpretations and other actions of the Committee shall be final and binding on all Offerees, all Optionees, and all
persons deriving their rights from an Offeree or Optionee. No member of the Committee shall be liable for any action that he or
she has taken or has failed to take in good faith with respect to the Plan, any Option, or any right to acquire Shares under the
Plan and, to the fullest extent permitted by law, all members of the Committee shall be indemnified by the Company and its Subsidiaries
for any liability and expenses which they may incur through any claim or cause of action arising under or in connection with this
Plan, any Option or any right to acquire Shares granted under this Plan.

 

(Q)     DELEGATION
OF AUTHORITY. The Committee may delegate its powers and duties under this Plan to the Company’s Chief Executive Officer
or other senior executive officer, subject to applicable law and such terms, conditions and limitations as the Committee may establish
in its sole discretion; provided, however, that the Committee may not delegate its powers and duties under this Plan with regard
to awards to the Company’s senior executive officers or any Offeree or Optionee who is a “covered employee”
as defined in section 162(m) of the Code. The Company shall furnish the Committee with such clerical and other assistance as is
necessary for the performance of the Committee’s duties under this Plan. In addition, the Committee may delegate ministerial
duties to any other person or persons, and it may employ attorneys, consultants, accountants or other professional advisers.

 

(R)     RIGHT
TO RECOUP. The Committee shall have full authority to adopt and enforce any policies and procedures adopted by the Company in
respect of section 10D of the Exchange Act and such regulations as are promulgated thereunder from time to time, or in respect
to any other applicable law, regulation or Company policy relating to the recoupment of amounts on account of a restatement of
a financial statement that, if initially reported properly, would have resulted in a lower amount being paid to an Offeree or
Optionee under the Plan, or in respect of any other policy of the Company relating to the recoupment of amounts on account of
the Offeree’s or Optionee’s breach of a non-competition, non-solicitation, non-disparagement or confidentiality obligation
as it deems necessary or appropriate in its sole discretion.

    -3- 

     

    

SECTION
3.

INTENTIONALLY
OMITTED

 

SECTION
4.

ELIGIBILITY.

 

(A)     GENERAL
RULES. Only Employees (including, without limitation, independent contractors, consultants and legal counsel who are not members
of the Board of Directors) shall be eligible for designation as Optionees or Offerees by the Committee. In addition, only Employees
who are common-law employees of the Company or a Subsidiary shall be eligible for the grant of ISOs. Employees who are Outside
Directors shall only be eligible for the grant of the Non-statutory Options described in Subsection (B) below.

 

(B)     OUTSIDE
DIRECTORS. Any other provision of the Plan notwithstanding, the participation of Outside Directors in the Plan shall be subject
to the following restrictions:

 

(i)       Outside
Directors shall receive no grants other than the Non-statutory Options described in this Subsection (B)

 

(ii)      All
Non-statutory Options granted to an Outside Director under this Subsection (B) shall become exercisable in full in the event of
the termination of such Outside Director’s service because of death or disability (within the meaning of section
22(e)(3) of the Code (“TOTAL AND PERMANENT DISABILITY”)).

 

(iii)     The
Exercise Price under all Non-statutory Options granted to an Outside Director under this Subsection (B) shall be not less than
100 percent of the Fair Market Value of a Share on the date of grant, and such Exercise Price shall be payable in one or more
of the forms of payment described in Subsection (A), (B), (C), (D) or (E) of Section 8.

 

The
Committee may provide that the Non-statutory Options that otherwise would be granted to an Outside Director under this Subsection
(B) shall instead be granted to an affiliate of such Outside Director. Such affiliate shall then be deemed to be an Outside Director
for purposes of the Plan, provided that the service-related vesting and termination provisions pertaining to the Non-statutory
Options shall be applied with regard to the service of the Outside Director.

 

SECTION
5.

STOCK
SUBJECT TO PLAN.

 

(A)     BASIC
LIMITATION. Shares offered under the Plan shall be authorized but unissued Shares or treasury Shares. The aggregate number of
Shares which may be issued under the Plan (upon exercise of Options or other rights to acquire Shares) shall not exceed 2,000,000
Shares, subject to adjustment pursuant to Section 9. The number of Shares which are subject to Options or other rights outstanding
at any time under the Plan shall not exceed the number of Shares which then remain available for issuance under the Plan. The
Company, during the term of the Plan, shall at all times reserve and keep available sufficient Shares to satisfy the requirements
of the Plan.

 

(B)     ISO
LIMITATION. The maximum number of Shares available with respect to all Options granted under this Plan that may be ISOs is
2,000,000.

 

(C)     INDIVIDUAL
PARTICIPANT ANNUAL LIMITATION. The maximum number of Shares underlying awards granted under this Plan to any one Optionee or Offeree
in any fiscal year, regardless of whether such awards are thereafter canceled, forfeited or terminated, shall not exceed 2,000,000.
The foregoing limitation is intended to include the grant of all awards under the Plan including, but not limited to, awards representing
“qualified performance-based compensation” under section 162(m) of the Code, and shall be applied based upon the assumption
that the maximum number of Shares shall be earned under any performance-based award.

 

(D)     ADDITIONAL
SHARES. In the event that any outstanding Option or other right for any reason expires or is cancelled or otherwise terminated,
the Shares allocable to the unexercised portion of such Option or other right shall again be available for the purposes of the
Plan. In the event that Shares issued under the Plan are reacquired by the Company pursuant to a forfeiture provision, a right
of repurchase or a right of first refusal, such Shares shall again be available for the purposes of the Plan.

    -4- 

     

    

SECTION
6.

TERMS
AND CONDITIONS OF AWARDS OR SALES.

 

(A)     AGREEMENT.
Each award or sale of Shares under the Plan (other than upon exercise of an Option) shall be evidenced by an agreement between
the Offeree and the Company (a “STOCK PURCHASE AGREEMENT”). Such award or sale shall be subject to all applicable
terms and conditions of the Plan and may be subject to any other terms and conditions which are not inconsistent with the Plan
and which the Committee deems appropriate for inclusion in such Stock Purchase Agreement. The provisions of the various Stock
Purchase Agreements entered into under the Plan need not be identical.

 

(B)     DURATION
OF OFFERS AND NONTRANSFERABILITY OF RIGHTS. Any right to acquire Shares under the Plan (other than an Option) shall automatically
expire if not exercised by the Offeree within 30 days after the grant of such right was communicated to the Offeree by the Committee.
Such right shall not be transferable and shall be exercisable only by the Offeree to whom such right was granted.

 

(C)     PURCHASE
PRICE. The purchase price of Shares to be offered for sale under the Plan shall not be less than 90 percent of the Fair Market
Value of such Shares. Subject to the preceding sentence, the purchase price shall be determined by the Committee at its sole discretion.
The purchase price shall be payable in a form of payment described in Section 8.

 

(D)     WITHHOLDING
TAXES. As a condition to the award or sale of Shares, the Offeree shall make such arrangements as the Committee may require for
the satisfaction of any federal, state, local or foreign withholding tax obligations that arise in connection with such Shares.
The Committee may permit the Offeree to satisfy all or part of his or her tax obligations related to such Shares by having the
Company withhold a portion of any Shares that otherwise would be issued to him or her or by surrendering any Shares that previously
were acquired by him or her. The Shares withheld or surrendered shall be valued at their Fair Market Value on the date when taxes
otherwise would be withheld. The payment of taxes by surrendering Shares to the Company, if permitted by the Committee, shall
be subject to such restrictions as the Committee may impose, including any restrictions required by rules of the Securities and
Exchange Commission.

 

(E)
    RESTRICTIONS ON TRANSFER OF SHARES. Any Shares awarded or sold under the Plan shall be subject to such forfeiture conditions,
rights of repurchase, rights of first refusal and other transfer restrictions as the Committee may determine. Such restrictions
shall be set forth in the applicable Stock Purchase Agreement and shall apply in addition to any general restrictions that may
apply to all shareholders of Shares.

 

SECTION 7.

TERMS
AND CONDITIONS OF OPTIONS.

 

(A)     STOCK
OPTION AGREEMENT. Each grant of an Option under the Plan shall be evidenced by a Stock Option Agreement between the Optionee and
the Company. Such Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms
and conditions which are not inconsistent with the Plan and which the Committee deems appropriate for inclusion in a Stock Option
Agreement. The provisions of the various Stock Option Agreements entered into under the Plan need not be identical.

 

(B)     NUMBER
OF SHARES. Each Stock Option Agreement shall specify the number of Shares that are subject to the Option and shall provide for
the adjustment of such number in accordance with Section 9. The Stock Option Agreement shall also specify whether the Option is
an ISO or a Non-statutory Option and, unless the grant of an Option is designated at the time of grant as an ISO, such Option
shall be a Non-statutory Option.

 

The
aggregate Fair Market Value (determined with respect to each ISO at the time such ISO is granted) of the Shares with respect to
which ISOs are exercisable for the first time by an Optionee during any calendar year (under this Plan or any other plan adopted
by the Company or its Subsidiary) shall not exceed $100,000. If such aggregate Fair Market Value shall exceed $100,000, such number
of ISOs as shall have an aggregate Fair Market Value equal to the amount in excess of $100,000 shall be treated as a Non-statutory
Option.

    -5- 

     

    

(C)     EXERCISE PRICE.
Each Stock Option Agreement shall specify the Exercise Price. The Exercise Price of an ISO shall not be less than 100 percent
of the Fair Market Value of a Share on the date of grant (110% of the Fair Market Value of the Shares if the following paragraph
applies).. The Exercise Price of a Non-statutory Option shall not be less than 100 percent of the Fair Market Value of a Share
on the date of grant. Subject to the preceding two sentences, the Exercise Price under any Option shall be determined by the Committee
at its sole discretion. The Exercise Price shall be payable in a form described in Section 8.

 

No
Employee may receive an ISO under this Plan if such Employee, at the time the Option is granted, owns (after application of the
rules contained in section 424(d) of the Code) equity securities representing more than 10% of the total combined voting power
of all classes of equity securities of the Company or any Subsidiary, unless (i) the Exercise Price for such ISO is at least 110%
of the Fair Market Value of the Shares as of the date of grant and (ii) such ISO is not exercisable on or after the fifth anniversary
of the date of grant.

 

(D)     WITHHOLDING
TAXES. As a condition to the exercise of an Option, the Optionee shall make such arrangements as the Committee may require for
the satisfaction of any federal, state, local or foreign withholding tax obligations that arise in connection with such exercise.
The Optionee shall also make such arrangements as the Committee may require for the satisfaction of any federal, state, local
or foreign withholding tax obligations that may arise in connection with the disposition of Shares acquired by exercising an Option.
The Committee may permit the Optionee to satisfy all or part of his or her tax obligations related to the Option by having the
Company withhold a portion of any Shares that otherwise would be issued to him or her or by surrendering any Shares that previously
were acquired by him or her. Such Shares shall be valued at their Fair Market Value on the date when taxes otherwise would be
withheld. The payment of taxes by surrendering Shares to the Company, if permitted by the Committee, shall be subject to such
restrictions as the Committee may impose, including any restrictions required by rules of the Securities and Exchange Commission.

 

(E)     EXERCISABILITY
AND TERM. Each Stock Option Agreement shall specify the date when all or any portion of the Shares subject to the Option is to
become exercisable. The exercisability of any Option shall be determined by the Committee at its sole discretion. A Stock Option
Agreement may provide for accelerated exercisability in the event of the Optionee’s death, Total and Permanent Disability
or retirement or other events. The Stock Option Agreement shall also specify the term of the Option. The term shall not exceed
10 years from the date of grant (5 years if the second paragraph of Section 7(C) applies). The Committee may extend the term of
an Option, in its discretion, but not beyond the date immediately prior to the tenth anniversary of the original date of grant.
If a definite term is not specified by the Committee at the time of grant, then the term is deemed to be 10 years. Subject to
the preceding sentence, the Committee at its sole discretion shall determine when an Option is to expire.

 

(F)     NONTRANSFERABILITY.
During an Optionee’s lifetime, such Optionee’s Option(s) shall be exercisable only by him or her (or his or her guardian
or legal representative to the extent permitted by applicable law) and shall not be transferable, unless permitted by the Stock
Option Agreement in a manner consistent with the immediately following paragraph. In the event of an Optionee’s death, such
Optionee’s Option(s) shall not be transferable other than by will, by a beneficiary designation executed by the Optionee
and delivered to the Company, or by the laws of descent and distribution.

 

The
Committee, in its discretion, may allow at or after the time of grant the transferability of Options that are exercisable, provided
that the permitted transfer (i) is made pursuant to a qualified domestic relations order or other applicable domestic relations
order to the extent permitted by law; (ii) if the Option is an ISO, is consistent with section 422 of the Code; (iii) is made
to the Company, an affiliate or a person acting as the agent of the foregoing or is otherwise determined by the Committee to be
in the interests of the Company or an affiliate thereof; or (iv) is made by the Optionee for no consideration to Immediate Family
Members or to a bona fide trust, partnership or other entity controlled by and for the benefit of one or more Immediate Family
Members. For this purpose, the term “Immediate Family Members” mean the Optionee’s spouse, children, stepchildren,
parents, stepparents, siblings (including half brothers and sisters), in-laws and other individuals who have a relationship to
the Optionee arising because of a legal adoption. No transfer may be made to the extent that transferability would cause Form
S-8 or any successor form thereto not to be available to register Shares related to an award under this Plan, and no Option granted
under the Plan may be transferred for value. The Committee in its discretion may impose additional terms and conditions upon transferability.

    -6- 

     

    

(G)     TERMINATION OF
SERVICE (EXCEPT BY DEATH). If an Optionee’s service terminates for any reason other than the Optionee’s death, then
such Optionee’s Option(s) shall expire on the earliest of the following occasions:

 

(i)       The
expiration date determined pursuant to Subsection (E) above;

 

(ii)      The
date 90 days after the termination of the Optionee’s service for any reason other than Total and Permanent Disability; or

 

(iii)     The
date six months after the termination of the Optionee’s service by reason of Total and Permanent Disability.

 

Notwithstanding
the foregoing, an Option granted to an Outside Director shall expire on the date determined pursuant to Subsection (E) above or
as such earlier date as may be set forth in the Stock Option Agreement. The Optionee may exercise all or part of his or her Option(s)
at any time before the expiration of such Option(s) under the preceding provisions of this Subsection (G), but only to the extent
that such Option(s) had become exercisable before the Optionee’s service terminated or became exercisable as a result of
such termination of service. The balance of such Option(s) shall expire when the Optionee’s service terminates. In the event
that the Optionee dies after the termination of the Optionee’s service but before the expiration of the Optionee’s
Option(s), all or part of such Option(s) may be exercised (prior to expiration) by his or her designated beneficiary (if applicable),
by the executors or administrators of the Optionee’s estate or by any person who has acquired such Option(s) directly from
the Optionee by bequest or inheritance, but only to the extent that such Option(s) had become exercisable before the Optionee’s
service terminated or became exercisable as a result of such termination of service.

 

(H)     LEAVES
OF ABSENCE. For purposes of Subsection (G) above, service shall be deemed to continue while the Optionee is on sick leave or other
bona fide leave of absence (as determined by the Committee). The foregoing notwithstanding, in the case of an ISO granted under
the Plan, service shall not be deemed to continue beyond the first 90 days of such leave, unless the Optionee’s reemployment
rights are guaranteed by an applicable statute or by contract.

 

(I)      DEATH
OF OPTIONEE. If an Optionee dies while he or she is in service, then such Optionee’s Option(s) shall expire on the earlier
of the following dates:

 

(i)       The
expiration date determined pursuant to Subsection (E) above; or

 

(ii)      The
date six months after the Optionee’s death.

 

Notwithstanding
the foregoing, an Option granted to an Outside Director shall expire on the date determined pursuant to Subsection (E) above or
as such earlier date as may be set forth in the Stock Option Agreement. All or part of the Optionee’s Option(s) may be exercised
at any time before the expiration of such Option(s) under the preceding provisions of this Subsection (I) by his or her designated
beneficiary (if applicable), by the executors or administrators of the Optionee’s estate or by any person who has acquired
such Option(s) directly from the Optionee by bequest or inheritance, but only to the extent that such Option(s) had become exercisable
before the Optionee’s death or became exercisable as a result of the Optionee’s death. The balance of such Option(s)
shall expire when the Optionee dies.

 

(J) NO
RIGHTS AS A STOCKHOLDER. An Optionee, or a transferee of an Optionee, shall have no rights as a stockholder with respect to any
Shares covered by his or her Option until the date of the issuance (as evidenced by the appropriate entry on the books of the
Company or of a duly authorized transfer agent of the Company) of a stock certificate for such Shares. No adjustments shall be
made, except as provided in Section 9.

    -7- 

     

    

(K)     MODIFICATION,
EXTENSION AND RENEWAL OF OPTIONS. Within the limitations of the Plan, the Committee may modify, extend or renew outstanding Options, provided
that no such modification, extension or renewal may (i) except as otherwise provided in Section 9 hereof, reduce the Exercise
Price to less than 100% of the Fair Market Value of the Shares as of the date of grant either by lowering the Exercise Price,
by canceling the outstanding Option in exchange for cash, other awards or a replacement Option with a lower Exercise Price, or
by the Company repurchasing an Option with an Exercise Price that is in excess of the Fair Market Value of the Shares at the time
of such repurchase, (ii) violate the terms and provisions of section 162(m) of the Code, or (iii) cause the Option to no longer
meet the requirements for exclusion from coverage under section 409A of the Code. The foregoing notwithstanding, no modification
of an Option shall, without the consent of the Optionee, impair such Optionee’s rights or increase his or her obligations
under such Option.

 

(L)     RESTRICTIONS
ON TRANSFER OF SHARES. Any Shares issued upon exercise of an Option shall be subject to such forfeiture conditions, rights of
repurchase, rights of first refusal and other transfer restrictions as the Committee may determine. Such restrictions shall be
set forth in the applicable Stock Option Agreement and shall apply in addition to any general restrictions that may apply to all
shareholders of Shares.

 

SECTION
8.

PAYMENT
FOR SHARES.

 

(A)     GENERAL
RULE. The entire purchase price or Exercise Price of Shares issued under the Plan shall be payable in lawful money of the United
States of America at the time when such Shares are purchased, except as follows:

 

(i)       In
the case of Shares sold under the terms of a Stock Purchase Agreement subject to the Plan, payment shall be made only pursuant
to the express provisions of such Stock Purchase Agreement. However, the Committee (at its sole discretion) may specify in the
Stock Purchase Agreement that payment may be made in one or more of the forms described in Subsections (F), (G) and (H) below.

 

(ii)      In
the case of an ISO granted under the Plan, payment shall be made only pursuant to the express provisions of the applicable Stock
Option Agreement. However, the Committee (at its sole discretion) may specify in the Stock Option Agreement that payment may be
made pursuant to one or more of the forms described in Subsections (B), (C), (D), (E). (G) or (H) below.

 

(iii)     In
the case of a Non-statutory Option granted under the Plan, the Committee (at its sole discretion) may accept payment pursuant
to one or more of the forms described in Subsections (B), (C), (D), (E), (G) or (H) below.

 

(B)     SURRENDER
OF STOCK. To the extent that this Subsection (B) is applicable, payment may be made all or in part with Shares which have already
been owned by the Optionee or his or her representative for more than 12 months and which are surrendered to the Company in good
form for transfer. Such Shares shall be valued at their Fair Market Value on the date when the Shares subject to the Option are
purchased under the Plan.

 

(C)     EXERCISE/SALE.
To the extent that this Subsection (C) is applicable, payment may be made by the delivery (on a form prescribed by the Company)
of an irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver all or part of the sales
proceeds to the Company in payment of all or part of the Exercise Price and any withholding taxes.

 

(D)     EXERCISE/PLEDGE.
To the extent that this Subsection (D) is applicable, payment may be made by the delivery (on a form prescribed by the Company)
of an irrevocable direction to pledge Shares to a securities broker or lender approved by the Company, as security for a loan,
and to deliver all or part of the loan proceeds to the Company in payment of all or part of the Exercise Price and any withholding
taxes.

    -8- 

     

    

(E)     CASHLESS
EXERCISE. To the extent that this Subsection (E) is applicable, payment made be made by means of a “cashless exercise”
in which the Optionee shall be entitled to receive a stock certificate for the number of Shares subject to the Option (or portion
thereof) exercised equal to the quotient obtained by dividing [((i) - (ii)) x (iii)] by (i), where:

 

(i)       is
equal to the aggregate Fair Market Value of the Shares that would be issued upon exercise of the Option by means of an exercise
by the payment of cash, determined as of the date the Option is exercised;

 

(ii)      is
equal to the aggregate Exercise Price of the Shares that would be issued upon exercise of the Option by means of an exercise by
the payment of cash, as may be adjusted by Section 9; and

 

(iii)     is
the number of Shares that would be issued upon exercise of the Option by means of an exercise by the payment of cash, rather than
a cashless exercise pursuant to this Subsection (E).

 

The
Company reserves, at any and all times, the right, in the Company’s sole and absolute discretion, to establish, decline
to approve or terminate any program or procedures for the exercise of Options by means of a cashless exercise under this Subsection
(E), including with respect to one or more Optionees specified by the Company notwithstanding that such program or procedures
may be available to other Optionees.

 

(F)     SERVICES
RENDERED. To the extent that this Subsection (F) is applicable, Shares may be offered for sale under the Plan in consideration
of services rendered to the Company or a Subsidiary prior to the offer. If Shares are offered for sale without the payment of
a purchase price in cash, the Committee shall make a determination (at the time of the award) of the value of the services rendered
by the Offeree and the sufficiency of the consideration to meet the requirements of Section 6(C).

 

(G)     PROMISSORY
NOTE. To the extent that this Subsection (G) is applicable, a portion of the purchase price or Exercise Price, as the case may
be, of Shares issued under the Plan may be payable by a full recourse promissory note, provided that (i) the par value of such
Shares must be paid in lawful money of the United States of America at the time when such Shares are purchased, (ii) the Shares
are security for payment of the principal amount of the promissory note and interest thereon, and (iii) the interest rate payable
under the terms of the promissory note shall be no less than the minimum rate (if any) required to avoid the imputation of additional
interest under the Code. Subject to the foregoing, the Committee (at its sole discretion) shall specify the term, interest rate,
amortization requirements (if any) and other provisions of such promissory note. Notwithstanding the foregoing, the purchase price
or Exercise Price of Shares issued under the Plan to a member of the Board of Directors or an executive officer (or equivalent
thereof) of the Company shall not be payable with a promissory note.

 

(H)     OTHER
FORMS OF PAYMENT. To the extent that this Subsection (H) is applicable, payment may be made in any other form approved by the
Committee, consistent with applicable laws, regulations and rules.

 

SECTION
9.

ADJUSTMENT
OF SHARES.

 

(A)    GENERAL.
In the event of a subdivision of the outstanding Shares, a declaration of a dividend payable in Shares, a declaration of a dividend
payable in a form other than Shares in an amount that has a material effect on the value of Shares, a combination or consolidation
of the outstanding Shares (by reclassification or otherwise) into a lesser number of Shares, a recapitalization, a spinoff or
a similar occurrence, the Committee shall make appropriate adjustments in one or more of (i) the number and type of Shares available
for future grants under Section 5, (ii) the limitations set forth in Sections 5(B) and(C), (iii) the number and type of Shares
covered by each outstanding Option, and (iii) the purchase price under each outstanding offer to purchase and the Exercise Price
under each outstanding Option.

 

Notwithstanding
the foregoing, the adjustments described in this Section 9(A) shall be made in compliance with: (x) sections 422 and 424 of the
Code with respect to ISOs; (y) section 162(m) of the Code with respect to “qualified performance-based compensation”
unless specifically determined otherwise by the Committee; and (z) section 409A of the Code with respect to Non-statutory Options
to the extent the Committee determines it is necessary to continue to avoid its application to such Options.

    -9- 

     

    

(B)     REORGANIZATIONS.
In the event that the company is a party to a merger or other reorganization, outstanding Options shall be subject to the agreement
of merger or reorganization. Such agreement may provide, without limitation, for the assumption of outstanding Options by the
surviving corporation or its parent, for their continuation by the Company (if the Company is a surviving corporation), for payment
of a cash settlement equal to the difference between the amount to be paid for one Share under such agreement and the Exercise
Price, or for the acceleration of their exercisability followed by the cancellation of Options not exercised, in all cases without
the Optionees’ consent. Any cancellation shall not occur until after such acceleration is effective and Optionees have been
notified of such acceleration. In the case of Options that have been outstanding for less than 12 months, a cancellation need
not be preceded by acceleration.

 

(C)     RESERVATION
OF RIGHTS. Except as provided in this Section 9, an Optionee or Offeree shall have no rights by reason of any subdivision
or consolidation of shares of stock of any class, the payment of any dividend or any other increase or decrease in the number
of shares of stock of any class. Any issue by the Company of shares of stock of any class, or securities convertible into shares
of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number or Exercise
Price of Shares subject to an Option. The grant of an Option pursuant to the Plan shall not affect in any way the right or power
of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, to merge
or consolidate, to dissolve, liquidate, sell or transfer all or any part of its business or assets, or to undertake any other
corporate act or proceeding by the Company.

 

SECTION
10.

SECURITIES
LAWS.

 

Shares
shall not be issued under the Plan unless the issuance and delivery of such Shares complies with (or is exempt from) all applicable
requirements of law, including (without limitation) the Securities Act of 1933, as amended, the rules and regulations promulgated
thereunder, state securities laws and regulations, and the regulations of any stock exchange on which the Company’s securities
may then be listed.

 

SECTION
11.

NO
RETENTION RIGHTS.

 

Neither
the Plan nor any Option shall be deemed to give any individual a right to remain an employee, consultant or director of the Company
or a Subsidiary. The Company and its Subsidiaries reserve the right to terminate the service of any employee, consultant or director,
at any time, with or without cause, subject to applicable laws, the Company’s certificate of incorporation and by-laws and
a written employment agreement (if any). No person shall have the right to be selected to receive an award under this Plan, or,
having been so selected, to be selected to receive a future award. The Committee’s determination under the Plan (including,
without limitation, determination of the Employees who shall be granted awards, the form, amount and timing of such awards, the
terms and conditions of awards) need not be uniform and may be made by it selectively among eligible Employees who receive or
are eligible to receive awards under the Plan, whether or not such eligible Employees are similarly situated.

 

SECTION
12.

DURATION AND
AMENDMENTS.

 

(A)    TERM
OF THE PLAN. The provisions of the Plan as set forth herein shall be effective retroactively to the Plan’s Original
Effective Date, except as otherwise expressly provided herein, subject to the approval of this amended and restated Plan by the
shareholders of the Company. The Plan shall terminate automatically after 15 years on January 24, 2036, except that no ISO may
be granted under this Plan on or after the tenth anniversary of the Effective Date of this Plan , and the Plan may be terminated
on any earlier date pursuant to Subsection (B) below.

 

(B)     RIGHT
TO AMEND OR TERMINATE THE PLAN. The Board of Directors may, subject to applicable law, amend, suspend or terminate the Plan at
any time and for any reason. An amendment to the Plan shall require stockholder approval only to the extent required by applicable
law, regulation or securities exchange requirements.

 

(C)     EFFECT
OF AMENDMENT OR TERMINATION. No Shares shall be issued or sold under the Plan after the termination thereof, except upon exercise
of an Option granted prior to such termination. The termination of the Plan or any amendment thereto shall not materially and
adversely affect any Share previously issued or any Option previously granted under the Plan without the Optionee’s written
consent thereto.

 

SECTION
13.

EXECUTION.

 

To
record the adoption and approval of this Plan by the Board of Directors and at least a majority vote of the holders of Shares,
the Company has caused its authorized officer to execute the same.

 

4DMED,
LTD.

 

By:
/s/ Hau Tin Cheung                              

 

       Hau Tin Cheung, its President

    -10-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]